PureTech Health Plc Forecast and Stock Analysis
Technical PRTC.L stock analysis for February 18, 2019.
PureTech Health Plc gained 0.30% in the last trading day, rising from £166.00 to £166.50 The price has risen in 6 of the last 10 days , but is still down by -2.06% for this period. Volume fell in the last day by -1 588 shares, and in total, 21 821 shares bought and sold for approximately £3.63 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Monday, 18th Feb 2019) of the PRTC.L stock was £166.50. This is 0.3% more than the trading day before Friday, 15th Feb 2019.
During day the stock fluctuated 1.20% from a day low at £166.50 to a day high of £168.50.
30 day high of the PRTC.L stock price was £178.00 and low was £165.50.
90 day high was £188.50 and low was £165.50.
52 week high for the PureTech Health Plc - £188.50 and low - £135.00.
PureTech Health Plc lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.19% during the next 3 months and, with 90% probability hold a price between £153.97 and £170.73 at the end of this period.
A buy signal was issued from a pivot bottom point on Friday February 15, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. PureTech Health Plc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at £171.64 and £172.02. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
PureTech Health Plc finds support from accumulated volume at £166.00.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved £2.00 (1.20%) between high and low. For the last week, the stock has had a daily average volatility of 1.35%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
PureTech Health Plc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.